This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glunde, K. Articles by Bhujwalla, Z. M. Search for Related Content PubMed PubMed Citation Articles by Glunde, K. Articles by Bhujwalla, Z. M.

RNA Interference–Mediated Choline Kinase Suppression in Breast Cancer Cells Induces Differentiation and Reduces Proliferation

John Hopkins University In Vivo Cellular Molecular Imaging Center Program, Russell H. Morgan Department of Radiology and Radiological Science, John Hopkins University School of Medicine, Baltimore, Maryland

Requests for reprints: Zaver M. Bhujwalla, Department of Radiology, John Hopkins University School of Medicine, 208C Traylor Building, 720 Rutland Avenue, Baltimore, MD 21205. Phone: 410-955-9698; Fax: 410-614-1948; E-mail: zaver{at}mri.jhu.edu.

Choline kinase is overexpressed in breast cancer cells and activated by oncogenes and mitogenic signals, making it a potential target for cancer therapy. Here, we have examined, for the first time, the effects of RNA interference (RNAi)–mediated down-regulation of choline kinase in nonmalignant and malignant human breast epithelial cell lines using magnetic resonance spectroscopy (MRS) as well as molecular analyses of proliferation and differentiation markers. RNAi knockdown of choline kinase reduced proliferation, as detected by proliferating cell nuclear antigen and Ki-67 expression, and promoted differentiation, as detected by cytosolic lipid droplet formation and expression of galectin-3. The functional importance of RNAi-mediated choline kinase down-regulation on choline phospholipid metabolism was confirmed by the significant reduction of phosphocholine detected by MRS. These results strongly support the targeting of choline kinase in breast cancer cells with RNAi and show the potential ability of noninvasive MRS to detect and evaluate future treatments incorporating such strategies.

This article has been cited by other articles:

				J. Leyton, G. Smith, Y. Zhao, M. Perumal, Q.-D. Nguyen, E. Robins, E. Arstad, and E. O. Aboagye [18F]Fluoromethyl-[1,2-2H4]-Choline: A Novel Radiotracer for Imaging Choline Metabolism in Tumors by Positron Emission Tomography Cancer Res., October 1, 2009; 69(19): 7721 - 7728. [Abstract] [Full Text] [PDF]

				B. Krishnamachary, K. Glunde, F. Wildes, N. Mori, T. Takagi, V. Raman, and Z. M. Bhujwalla Noninvasive Detection of Lentiviral-Mediated Choline Kinase Targeting in a Human Breast Cancer Xenograft Cancer Res., April 15, 2009; 69(8): 3464 - 3471. [Abstract] [Full Text] [PDF]

				V. P. Kovacheva, J. M. Davison, T. J. Mellott, A. E. Rogers, S. Yang, M. J. O'Brien, and J. K. Blusztajn Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival FASEB J, April 1, 2009; 23(4): 1054 - 1063. [Abstract] [Full Text] [PDF]

				F. Spadaro, C. Ramoni, D. Mezzanzanica, S. Miotti, P. Alberti, S. Cecchetti, E. Iorio, V. Dolo, S. Canevari, and F. Podo Phosphatidylcholine-Specific Phospholipase C Activation in Epithelial Ovarian Cancer Cells Cancer Res., August 15, 2008; 68(16): 6541 - 6549. [Abstract] [Full Text] [PDF]

				K. Glunde, T. Shah, P. T. Winnard Jr., V. Raman, T. Takagi, F. Vesuna, D. Artemov, and Z. M. Bhujwalla Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1{alpha} Signaling in a Human Prostate Cancer Model Cancer Res., January 1, 2008; 68(1): 172 - 180. [Abstract] [Full Text] [PDF]

				N. Mori, K. Glunde, T. Takagi, V. Raman, and Z. M. Bhujwalla Choline Kinase Down-regulation Increases the Effect of 5-Fluorouracil in Breast Cancer Cells Cancer Res., December 1, 2007; 67(23): 11284 - 11290. [Abstract] [Full Text] [PDF]

				I. Stasinopoulos, D. R. O'Brien, F. Wildes, K. Glunde, and Z. M. Bhujwalla Silencing of Cyclooxygenase-2 Inhibits Metastasis and Delays Tumor Onset of Poorly Differentiated Metastatic Breast Cancer Cells Mol. Cancer Res., May 1, 2007; 5(5): 435 - 442. [Abstract] [Full Text] [PDF]

				D. K. Meyerholz, J. A. DeGraaff, J. M. Gallup, A. K. Olivier, and M. R. Ackermann Depletion of Alveolar Glycogen Corresponds With Immunohistochemical Development of CD208 Antigen Expression in Perinatal Lamb Lung J. Histochem. Cytochem., November 1, 2006; 54(11): 1247 - 1253. [Abstract] [Full Text] [PDF]